Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1735051 10.3389/fphar.2025.1735051 Correction Correction: Editorial: Opportunities and challenges in drug repurposing Camps et al. 10.3389/fphar.2025.1735051 Camps Ihosvany 1 * Writing – original draft Writing – review & editing Künzel Stephan R. 2 3 Schubert Mario 4 Singh Ramendra K. 5 Institute of Exact Sciences, Federal University of Alfenas, Alfenas, Brazil Institute for Transfusion Medicine, DRK Blutspendedienst Nord-Ost gGmbH, Dresden, Germany Department for Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany Institute of Pharmacology and Toxicology, Technical University Dresden, Dresden, Germany Allahabad University Allahabad (Prayagraj), Allahabad, India Correspondence: Ihosvany Camps, icamps@unifal-mg.edu.br 11 11 2025 2025 16 1735051 29 10 2025 27 10 2025 30 10 2025 Copyright © 2025 Camps, Künzel, Schubert and Singh. 2025 Camps, Künzel, Schubert and Singh https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Editorial: Opportunities and challenges in drug repurposing by Camps I, Künzel SR, Schubert M and Singh RK (2025). Front. Pharmacol. 16:1709217. doi: 10.3389/fphar.2025.1709217 drug repurposing drug repositioning challenges opportunities artificial intelligence bioinformatics section-in-acceptance Experimental Pharmacology and Drug Discovery

The accession date was omitted for reference “Maida, 2024”. It should be “Maida, J. (2024). Drug repurposing market to grow by USD 8.57 billion (2024–2028) as cancer treatment applications expand, AI-driven market transformation report–technavio. Cleveland, OH, United States: PR Newswire Website. Available online at: https://www.prnewswire.com/news-releases/drug-repurposing-market-togrow-by-usd-8-57-billion-2024-2028-as-cancer-treatment-applications-expand-aidriven-market-transformation-report—technavio-302292477.html. (Accessed September 17, 2025)”.

The accession date was omitted for reference “Sperry and Ingber, 2024”. It should be “Sperry, M., and Ingber, D. (2024). Drug repurposing strategies, challenges and successes. Website Technol. Drug Discov. Available online at: https://www.technologynetworks.com/drug-discovery/articles/drug-repurposing-strategieschallenges-and-successes-384263. (Accessed September 17, 2025)”.

The reference for “Maximize Market Research, 2017” was erroneously written as “The Global Business Consultancy Firm (2017). Maximize MARKET RESEARCH. Pune, Maharashtra, India. Maximize Market Research Pvt Ltd. Available online at: https://www.maximizemarketresearch.com/ (Accessed date on November 28, 2017)”. It should be “Maximize Market Research. (2017). Drug Repurposing Market: Strategic Approaches, Technological Advancements, Market Dynamics, and Future Growth Outlook (2025–2032). Available online at: https://www.maximizemarketresearch.com/market-report/drug-repurposing-market/273130/ (Accessed September 17, 2025)”.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland